A review on targeted therapies for lung cancer

A review on targeted therapies for lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Ashraf, Anushey
Rannpháirtithe:	Khan, Tanisha Tabassum Sayka
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	Brac University 2023
Ábhair:	Lung cancer Antibodies Targeted therapy Vaccines Lung cancer > Treatment
Rochtain ar líne:	http://hdl.handle.net/10361/19353

Míreanna comhchosúla

Immunotherapy in the Management of Lung Cancer
de réir: Tasnim, Humayra
Foilsithe / Cruthaithe: (2022)

Potential of liposomes for the treatment of lung cancer- a review
de réir: Mim, Shanzida
Foilsithe / Cruthaithe: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
de réir: Tania, Umme
Foilsithe / Cruthaithe: (2023)

Molecules associated with the development of lung cancer
de réir: Rahman, Adree, et al.
Foilsithe / Cruthaithe: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
de réir: Paul, Pulock
Foilsithe / Cruthaithe: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
de réir: Rahman, Tasnim
Foilsithe / Cruthaithe: (2024)

A review on recent advances in drugs for lung cancer treatment
de réir: Noor, Fouzia
Foilsithe / Cruthaithe: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
de réir: Jeba, Joynob
Foilsithe / Cruthaithe: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
de réir: Razna, Amrin Islam
Foilsithe / Cruthaithe: (2019)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
de réir: Flora, Sanzida Alam
Foilsithe / Cruthaithe: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
de réir: Pial, Sazia Afrin
Foilsithe / Cruthaithe: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
de réir: Zangmo, Thinley
Foilsithe / Cruthaithe: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
de réir: Hoque, Ismoth Ara
Foilsithe / Cruthaithe: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
de réir: Shabnam, Musharrat
Foilsithe / Cruthaithe: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
de réir: Bristy, Israt Zerin
Foilsithe / Cruthaithe: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
de réir: Alam, Kazi Tasnuva
Foilsithe / Cruthaithe: (2022)

Lung cancer detection and classification using machine learning
de réir: Arefin, Mahbubul, et al.
Foilsithe / Cruthaithe: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
de réir: Das, Reshita
Foilsithe / Cruthaithe: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
de réir: Jahan, Nusrat
Foilsithe / Cruthaithe: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
de réir: Nandy, Aditi
Foilsithe / Cruthaithe: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
de réir: Mukti, Roushney Fatima, et al.
Foilsithe / Cruthaithe: (2016)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
de réir: Kamal, Tasnova
Foilsithe / Cruthaithe: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
de réir: Nahar, Kamrun
Foilsithe / Cruthaithe: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
de réir: Ratu, Tabassum
Foilsithe / Cruthaithe: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
de réir: Parvez, Safi
Foilsithe / Cruthaithe: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
de réir: Meem, Manila
Foilsithe / Cruthaithe: (2023)

A comprehensive review on drug repurposing in cancer treatment
de réir: Sarkar, Onusree
Foilsithe / Cruthaithe: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
de réir: Nashrah, Zannatul
Foilsithe / Cruthaithe: (2023)

Breast cancer therapy through Liposomal drug delivery system
de réir: Ome, Nusrat Jahan
Foilsithe / Cruthaithe: (2024)

Trend in approval of targeted biologics in the last two decades
de réir: Siddika, Khadiza
Foilsithe / Cruthaithe: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
de réir: Hasan, Amit
Foilsithe / Cruthaithe: (2024)

Current practice and approaches of immunotherapy in Cancer treatment
de réir: Khondokar, Faiza
Foilsithe / Cruthaithe: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
de réir: Karim, Samia Binte
Foilsithe / Cruthaithe: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
de réir: Alam, Tahera
Foilsithe / Cruthaithe: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
de réir: Abir, Shifaty Nur
Foilsithe / Cruthaithe: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
de réir: Rahman, Samia
Foilsithe / Cruthaithe: (2022)

A review on potential of PARP inhibitors in the treatment of prostate cancer
de réir: Islam, Saidul
Foilsithe / Cruthaithe: (2022)

The uses of bacteria in cancer therapy
de réir: Saha, Shimul, et al.
Foilsithe / Cruthaithe: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
de réir: Chakraborty, Anuradha
Foilsithe / Cruthaithe: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
de réir: Tania, Umme
Foilsithe / Cruthaithe: (2021)